GILD

Gilead Sciences (GILD)

Gilead Sciences Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:GILD

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/06/05	15:00	Business Wire	Gilead’s Seladelpar Demonstrated a Sustained and Consistent Long-Term Efficacy and Safety Profile in Primary Biliary Cholangitis	NASDAQ:GILD	Gilead Sciences Inc
2024/06/03	23:00	Business Wire	Kite’s Tecartus® Demonstrates Sustained Overall Survival in Adult Patients With Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia	NASDAQ:GILD	Gilead Sciences Inc
2024/06/03	22:00	Business Wire	Encouraging New Data Presented on Kite’s Yescarta® for Relapsed/Refractory Central Nervous System Lymphoma	NASDAQ:GILD	Gilead Sciences Inc
2024/06/02	21:00	Business Wire	Gilead and Arcus Announce Etrumadenant Plus Zimberelimab Regimen Significantly Reduced the Risk of Death in Third-line Metastatic Colorectal Cancer	NASDAQ:GILD	Gilead Sciences Inc
2024/06/02	21:00	Business Wire	Gilead and Arcus Announce Etrumadenant Plus Zimberelimab Regimen Significantly Reduced the Risk of Death in Third-line Metastatic Colorectal Cancer	NASDAQ:GILD	Gilead Sciences Inc
2024/06/01	21:00	Business Wire	Gilead and Arcus Announce Anti-TIGIT Domvanalimab Plus Zimberelimab and Chemotherapy Exceeded One Year of Median Progression-Free Survival as a First-Line Treatment for Upper GI Cancers	NASDAQ:GILD	Gilead Sciences Inc
2024/06/01	21:00	Business Wire	Gilead and Arcus Announce Anti-TIGIT Domvanalimab Plus Zimberelimab and Chemotherapy Exceeded One Year of Median Progression-Free Survival as a First-Line Treatment for Upper GI Cancers	NASDAQ:GILD	Gilead Sciences Inc
2024/05/31	21:07	Business Wire	EVOKE-01 Study Results in Metastatic NSCLC to Be Presented at an Oral Session at ASCO 2024	NASDAQ:GILD	Gilead Sciences Inc
2024/05/31	05:45	Business Wire	Gilead Provides Update on Phase 3 TROPiCS-04 Study	NASDAQ:GILD	Gilead Sciences Inc
2024/05/22	21:30	Business Wire	Gilead to Present Latest Research Across Key Liver Disease Indications at the European Association for the Study of the Liver Congress 2024	NASDAQ:GILD	Gilead Sciences Inc
2024/05/18	21:30	Business Wire	Investigational Seladelpar Demonstrates Significant Improvements in Liver Disease Progression and Reduced Itching in Primary Biliary Cholangitis	NASDAQ:GILD	Gilead Sciences Inc
2024/05/14	23:09	Business Wire	Kite Data at EHA 2024 Demonstrate Positive Patient Outcomes and Advances in Delivery of CAR T-cell Therapy	NASDAQ:GILD	Gilead Sciences Inc
2024/05/10	06:57	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:GILD	Gilead Sciences Inc
2024/05/10	06:30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:GILD	Gilead Sciences Inc
2024/05/10	06:26	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:GILD	Gilead Sciences Inc
2024/05/10	06:23	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:GILD	Gilead Sciences Inc
2024/05/10	06:16	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:GILD	Gilead Sciences Inc
2024/05/10	06:08	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:GILD	Gilead Sciences Inc
2024/05/10	05:11	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:GILD	Gilead Sciences Inc
2024/05/10	05:05	Business Wire	Kite and Arcellx Continue Momentum with Advances in Anito-Cel Multiple Myeloma Program	NASDAQ:GILD	Gilead Sciences Inc
2024/05/10	04:46	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:GILD	Gilead Sciences Inc
2024/05/10	04:38	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:GILD	Gilead Sciences Inc
2024/05/09	05:58	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:GILD	Gilead Sciences Inc
2024/05/07	21:30	Business Wire	Gilead and Kite Oncology to Highlight Broad and Diverse Oncology Portfolio at ASCO 2024	NASDAQ:GILD	Gilead Sciences Inc
2024/05/01	05:05	Business Wire	Gilead Sciences to Present at Upcoming Investor Conferences	NASDAQ:GILD	Gilead Sciences Inc
2024/04/26	21:00	Business Wire	FDA Approves Biktarvy® Label Update With Data for Pregnant Adults With HIV	NASDAQ:GILD	Gilead Sciences Inc
2024/04/26	20:47	IH Market News	Exxon Mobil Net Profit Drops 28% to $8.22 Billion, Atlassian Surprises with Revenue Boost and Co-CEO Exit, and More in Earnings	NASDAQ:GILD	Gilead Sciences Inc
2024/04/26	05:02	Business Wire	Gilead Sciences Announces First Quarter 2024 Financial Results	NASDAQ:GILD	Gilead Sciences Inc
2024/04/25	20:53	IH Market News	U.S. Futures Drop in Pre-Market Trading as Tech Stocks Plunge After Meta Issues Gloomy Forecast	NASDAQ:GILD	Gilead Sciences Inc
2024/04/09	05:05	Business Wire	Gilead Sciences to Release First Quarter 2024 Financial Results on Thursday, April 25, 2024	NASDAQ:GILD	Gilead Sciences Inc